Handelsbanken Fonder’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $381K | Buy |
23,800
+2,900
| +14% | +$46.4K | ﹤0.01% | 1355 |
|
2025
Q1 | $357K | Hold |
20,900
| – | – | ﹤0.01% | 1352 |
|
2024
Q4 | $518K | Hold |
20,900
| – | – | ﹤0.01% | 1270 |
|
2024
Q3 | $596K | Buy |
20,900
+4,700
| +29% | +$134K | ﹤0.01% | 1174 |
|
2024
Q2 | $428K | Buy |
16,200
+4,400
| +37% | +$116K | ﹤0.01% | 1219 |
|
2024
Q1 | $381K | Hold |
11,800
| – | – | ﹤0.01% | 1287 |
|
2023
Q4 | $497K | Buy |
11,800
+2,900
| +33% | +$122K | ﹤0.01% | 1153 |
|
2023
Q3 | $342K | Buy |
+8,900
| New | +$342K | ﹤0.01% | 1253 |
|
2021
Q1 | – | Sell |
-7,100
| Closed | -$328K | – | 1572 |
|
2020
Q4 | $328K | Buy |
+7,100
| New | +$328K | ﹤0.01% | 1363 |
|